149 related articles for article (PubMed ID: 17555114)
1. [Anemia in chronic lymphatic leukemia: is erythropoietin the solution?].
de Gaona ER; Rifón J; Pérez-Calvo J; Bendandi M; Iglesias R; Panizo C
Rev Med Univ Navarra; 2007; 51(1):3-10. PubMed ID: 17555114
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin and chronic lymphocytic leukemia.
Mauro FR; Gentile M; Foa R
Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
[TBL] [Abstract][Full Text] [Related]
3. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Karlsson C; Hansson L; Celsing F; Lundin J
Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
[TBL] [Abstract][Full Text] [Related]
4. Phase III clinical trials with darbepoetin: implications for clinicians.
Glaspy J
Best Pract Res Clin Haematol; 2005; 18(3):407-16. PubMed ID: 15792914
[TBL] [Abstract][Full Text] [Related]
5. Correction of disease related anaemia of B-chronic lymphoproliferative disorders by recombinant human erythropoietin: maintenance is necessary to sustain response.
Siakantaris MP; Angelopoulou MK; Vassilakopoulos TP; Dimopoulou MN; Kontopidou FN; Pangalis GA
Leuk Lymphoma; 2000 Dec; 40(1-2):141-7. PubMed ID: 11426615
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
8. [Treatment with cyclosporin A of the anemia associated with chronic lymphatic leukemia].
Rozman M; Montserrat E; Cervantes F; Bladé J; Marín P; Rozman C
Sangre (Barc); 1990 Aug; 35(4):321-5. PubMed ID: 2148838
[TBL] [Abstract][Full Text] [Related]
9. [Splenectomy of chronic lymphatic leukemia].
López Guillermo A; Pereira A; Montserrat E; Rozman C
Sangre (Barc); 1988 Aug; 33(4):287-90. PubMed ID: 3187846
[No Abstract] [Full Text] [Related]
10. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietic agents in the management of cancer patients. Part 1: Anemia, quality of life, and possible effects on survival.
Smith RE
J Support Oncol; 2003; 1(4):249-56, 258-9; discussion 257-8. PubMed ID: 15334867
[TBL] [Abstract][Full Text] [Related]
12. [Chronic B-cell lymphatic leukemia: autoimmune hemolytic anemias versus anemias caused by marrow failure].
Orfao A; González M; San Miguel JF; Corral M; Nieto MJ; Cañizo MC; Hernández J; Fernández Calvo J; López Borrasca A
Sangre (Barc); 1988 Aug; 33(4):296-300. PubMed ID: 3187848
[No Abstract] [Full Text] [Related]
13. [Preliminary results of erythropoietin treatment of anemia in myelodysplastic syndromes and chronic lymphocytic leukemia].
Gałeza-Obrepalska B; Dwilewicz-Trojaczek J; Paszkowska M; Kuratowska Z
Pol Tyg Lek; 1996 May; 51(19-22):285-8. PubMed ID: 9289712
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of erythropoietin in anemia of patients with immuno-lymphoproliferative disease].
Longo G; Fiorani C; Bonacorsi G; Vanzanelli P; Sani F; Bevini M; Curci G; Torelli U
Recenti Prog Med; 1992; 83(7-8):449-54. PubMed ID: 1529159
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: a case series and review of the literature.
Hill J; Walsh RM; McHam S; Brody F; Kalaycio M
Am J Hematol; 2004 Mar; 75(3):134-8. PubMed ID: 14978692
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option.
Cornes P; Coiffier B; Zambrowski JJ
Curr Med Res Opin; 2007 Feb; 23(2):357-68. PubMed ID: 17288690
[TBL] [Abstract][Full Text] [Related]
17. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
18. Splenectomy in advanced chronic lymphocytic leukemia.
Thiruvengadam R; Piedmonte M; Barcos M; Han T; Henderson ES
Leukemia; 1990 Nov; 4(11):758-60. PubMed ID: 2232888
[TBL] [Abstract][Full Text] [Related]
19. Evaluating erythropoietic agents for the treatment of anaemia in the oncology setting.
Gascón P
Eur J Cancer; 2005 Nov; 41(17):2601-12. PubMed ID: 16230006
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Cascavilla N
Leuk Lymphoma; 2007 Jun; 48(6):1072-80. PubMed ID: 17577769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
